This inventor holds 1 USPTO granted patent. Top assignee: Prelude Therapeutics Incorporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jialiang Wang: Innovator in BCL-2 Inhibitors
Introduction
Jialiang Wang is a prominent inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on BCL-2 inhibitors. His innovative approach has the potential to impact cancer treatment and other therapeutic areas.
Latest Patents
Jialiang Wang holds a patent for "BCL-2 inhibitors and their use as pharmaceuticals." This patent focuses on BCL-2 inhibitors, pharmaceutical compositions that include these compounds, and methods for their use and preparation. His work in this area is crucial for developing new treatment options.
Career Highlights
Wang is associated with Prelude Therapeutics Incorporated, where he continues to advance his research and development efforts. His expertise in pharmaceuticals and innovative thinking have positioned him as a valuable asset in the industry.
Collaborations
Jialiang Wang collaborates with talented individuals such as Jincong Zhuo and Andrew Paul Combs. These partnerships enhance the research and development process, fostering innovation and progress in their projects.
Conclusion
Jialiang Wang's contributions to the field of pharmaceuticals, particularly through his patent on BCL-2 inhibitors, highlight his role as an influential inventor. His work has the potential to lead to significant advancements in cancer treatment and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile